Long: molecular tracking of CML with bilineal inv(16) myeloid and del(9) lymphoid blast crisis and durable response to CD19-directed CAR-T therapy

Leukemia. 2020 Nov;34(11):3050-3054. doi: 10.1038/s41375-020-0983-x. Epub 2020 Jul 16.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD19* / immunology
  • Blast Crisis / genetics*
  • Blast Crisis / pathology
  • Disease Management
  • Disease Susceptibility
  • Humans
  • Immunotherapy, Adoptive* / methods
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Male
  • Oncogene Proteins, Fusion / genetics*
  • Receptors, Chimeric Antigen / genetics
  • Receptors, Chimeric Antigen / immunology
  • Treatment Outcome
  • Young Adult

Substances

  • Antigens, CD19
  • Oncogene Proteins, Fusion
  • Receptors, Chimeric Antigen
  • inv(16) fusion protein, human